Wednesday, November 25, 2009, 10:41am SGT - The Singapore stock market closes in 6 hours and 19 minutes.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Talecris Biotherapeutics Holdings Corp. (TLCR)

At 5:00AM SGT: 20.18 USD  Up 0.90 (4.67%)  
 MORE ON TLCR 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Talecris Biotherapeutics Holdin (NasdaqNM:TLCR) Delayed quote dataEdit
After Hours: 20.17 Down 0.01 (0.05%) as of 5:00am SGT on 11/25/09
Last Trade:20.18 USD
Trade Time:5:00AM SGT
Change:Up 0.90 (4.67%)
Prev Close:19.28
Open:19.32
Bid:19.05 x 500
Ask:N/A
1y Target Est:25.40
Day's Range:18.73 - 20.38
52wk Range:18.01 - 23.44
Volume:575,761
Avg Vol (3m):1,382,090
Market Cap:2.42B
P/E (ttm):10.68
EPS (ttm):1.89
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m 
Use Y! Toolbar to track stocks
 Add TLCR to Portfolio   Download Data

 HEADLINES 
•Biotech Stocks Hot Right Now, Ho-Hum in the Long Run
at The Wall Street Journal Online (Wed, Nov 18)
•Talecris to invest $268.7 million in NC plant
AP (Sat, Nov 14)
•Talecris to Invest $268.7 Million to Expand its Manufacturing Facility in Clayton
Business Wire (Sat, Nov 14)
•There Will Be Blood (Plasma)
at Motley Fool (Thu, Nov 12)
•Coverage initiated on Talecris Biotherapeutics by Barclays Capital and Citigroup
Briefing.com (Wed, Nov 11)
•Talecris Biotherapeutics Holdings Corp. Earnings Call scheduled for 8:30 am ET today
CCBN (Tue, Nov 10)
•TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Financial
EDGAR Online (Tue, Nov 10)
•Talecris Biotherapeutics Announces Third Quarter 2009 Results
Business Wire (Tue, Nov 10)
•TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Tue, Nov 10)
•Q3 2009 Talecris Biotherapeutics Holdings Corp. Earnings Release - After Market Close
CCBN (Mon, Nov 9)
More Headlines for TLCR...
 ANALYST 
EPS Est (next year) (Dec-09) :1.36
EPS Est (in 2 years) (Dec-10) :1.52
Avg Rec (current)*:2.0
PEG Ratio:0.95
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Talecris Biotherapeutics Holdings Corp., a biotherapeutic and biopharmaceutical company, engages in the production and marketing of plasma-derived protein therapies worldwide.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices